Model Informed Drug Development Archives | 第 9 页，共 42 页 | Certara

Poster

Simulating the effect of anti-diabetic drugs on ATP-sensitive potassium (KATP) channels inhibition in a human cardiac cell model (ORd)

Danielle Pillsbury2019 年 8 月 23 日

海报

Application of a PBPK model for prediction of the DDI between Lorazepam and Probenecid.

Danielle Pillsbury2019 年 8 月 22 日

Poster

What Sample Size to Use When Designing Paediatric Pharmacokinetic Studies? A Critical Analysis of “Precision Criteria”

Danielle Pillsbury2019 年 8 月 22 日

Poster

T4.1 – Setting the framework for database and development of this database

Danielle Pillsbury2019 年 8 月 22 日

Poster

Modelling Toxicodynamic Feedback is Critical in Recovering Toxicokinetics in Acetaminophen Overdose

Danielle Pillsbury2019 年 8 月 9 日

Poster

Development and Performance Evaluation of a semi-mechanistic PBPK Model for Topical Ocular Delivery of Pilocarpine and Timolol to Rabbit Eye

Danielle Pillsbury2019 年 6 月 24 日

Poster

Transporter inhibition: modelling in-vitro Transwell Assays

Danielle Pillsbury2019 年 6 月 24 日

White Paper

利用 QSP 优化免疫肿瘤药物发现与开发

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

Danielle Pillsbury2019 年 6 月 19 日

Brochure

Pirana 建模工作平台

Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for…

Danielle Pillsbury2019 年 5 月 28 日

Publication

Precision Dosing in Clinical Medicine: Present and Future

Danielle Pillsbury2018 年 7 月 20 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software